Concomitant Gastric Malignancy and Hepatocellular Carcinoma.

epstein- barr virus gastric malignancy hepatitis c virus (hcv) hepatocellular carcinoma (hcc) lymphoepithelioma-like carcinoma multiple primary malignant neoplasm primary liver lesion stomach ulcer

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jun 2022
Historique:
accepted: 02 06 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 11 6 2022
Statut: epublish

Résumé

Multiple primary malignant tumors (MPMTs) are two or more separate malignancies found at different sites concurrently. Prior studies have shown that the most common tumor associations in MPMTs are typically between two tumors in the digestive system. We present a case of a male patient in his 60s who initially presented with melena and was found to have a clean-based gastric ulcer on initial endoscopic evaluation. Repeat endoscopy on later admission revealed persistent ulceration. Biopsy showed Epstein-Barr virus (EBV) positive lymphoepithelioma-like gastric carcinoma (LELGC), a rare gastric malignancy. The patient underwent endoscopic ultrasound (EUS) for assessment of tumor depth and involvement of perigastric lymph nodes, but was incidentally found to have a liver lesion. Biopsy of the liver lesion was positive for hepatocellular carcinoma (HCC) with no morphologic similarity to the gastric malignancy. This case highlights a rare finding of MPMTs. In addition to the diagnosis of a rare gastric malignancy, the patient developed a well-known but uncommon phenomenon of non-cirrhotic HCC associated with hepatitis C virus (HCV). Due to an increasing number of advances in cancer therapy that are leading to increased survival times, clinicians can expect for a patient to develop MPMTs in their lifetime. A high index of suspicion must exist for the possibility of MPMTs because treatment options and outcomes can be vastly affected by their findings.

Identifiants

pubmed: 35686196
doi: 10.7759/cureus.25607
pmc: PMC9170374
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e25607

Informations de copyright

Copyright © 2022, Mathew et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Cancer. 2018 Jul 16;9(16):2795-2801
pubmed: 30123347
J Clin Oncol. 2004 Feb 15;22(4):664-70
pubmed: 14966089
World J Gastroenterol. 2005 Jul 21;11(27):4215-9
pubmed: 16015692
Medicine (Baltimore). 2017 Apr;96(17):e6799
pubmed: 28445321
Mod Pathol. 2003 Jul;16(7):641-51
pubmed: 12861059
Oncol Lett. 2016 Apr;11(4):2491-2496
pubmed: 27073504
Cancer Detect Prev. 1989;13(5-6):287-92
pubmed: 2663155
World J Gastroenterol. 2021 Jun 28;27(24):3466-3482
pubmed: 34239263
World J Gastroenterol. 2016 Mar 14;22(10):3056-61
pubmed: 26973402
World J Hepatol. 2019 Jan 27;11(1):1-18
pubmed: 30705715
Gastroenterology. 2002 Feb;122(2):366-75
pubmed: 11832451

Auteurs

Reshmi Mathew (R)

Internal Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.

Gregory Churchill (G)

Gastroenterology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.

Bakht Cheema (B)

Gastroenterology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.

Ketav Desai (K)

Pathology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.

Ahmad Alkhasawneh (A)

Pathology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.

Shiguang Liu (S)

Pathology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.

Anwer Siddiqi (A)

Pathology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.

Classifications MeSH